Literature DB >> 1892465

HLA population genetics.

G Thomson.   

Abstract

The HLA system has been extensively studied from an evolutionary perspective. The region contains a number of closely linked genes whose products control a variety of functions concerned with the regulation of immune responses. In addition, the genetic predisposition to over 40 diseases maps to this region. A number of observations indicate that strong selection is acting on the HLA region, including its extensive polymorphism with very even allele frequencies, the preferential occurrence of high levels of variability at positions critical to antigen recognition, the great age of alleles and the patterns of linkage disequilibrium among loci. The form of the selection is unknown. Although balancing selection is a strong candidate, it seems unlikely that only one selective mechanism is operating in this complex multigene family region. Mutation, recombination and gene conversion all contribute to the generation of HLA variability. The apparent great age of many HLA alleles revealed by phylogenetic analysis suggests that the absolute rate of production of new variants is not high. Detailed studies of population and evolutionary features of the HLA region are necessary for an informed discussion of the evolution of disease predisposing genes and epitopes, and of complex multigene families.

Mesh:

Substances:

Year:  1991        PMID: 1892465     DOI: 10.1016/s0950-351x(05)80126-0

Source DB:  PubMed          Journal:  Baillieres Clin Endocrinol Metab        ISSN: 0950-351X


  2 in total

1.  Identifying the susceptibility gene(s) in a set of trait-linked genes using genotype data.

Authors:  Ao Yuan; Guanjie Chen; Yuanxiu Chen; Charles Rotimi; George E Bonney
Journal:  Genetics       Date:  2004-07       Impact factor: 4.562

2.  A haplotype at STAT2 Introgressed from neanderthals and serves as a candidate of positive selection in Papua New Guinea.

Authors:  Fernando L Mendez; Joseph C Watkins; Michael F Hammer
Journal:  Am J Hum Genet       Date:  2012-08-10       Impact factor: 11.025

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.